LAROCHE RICHARD F JR 4

4 · NATIONAL HEALTHCARE CORP · Filed May 1, 2024

Form 4

Period: 2024-04-30

Director

Transactions

Exercise/Conversion
Option to Purchase Common Stock [2019 Grant]
2024-04-30−4,000→ 3,500 total
Exercise: $77.92From: 2019-05-09Exp: 2024-05-08→ Common Stock (7,500 underlying)
Exercise/Conversion
Option to Purchase Common Stock [2019 Grant]
2024-04-30−3,500→ 0 total
Exercise: $77.92From: 2019-05-09Exp: 2024-05-08→ Common Stock (3,500 underlying)
Exercise/Conversion
Common Stock (held in my name or my wife's name)
2024-04-30$77.92/sh+4,000$311,680→ 0 total
Exercise/Conversion
Common Stock (held in my name or my wife's name)
2024-04-30$77.92/sh+3,500$272,720→ 0 total
Tax Payment
Common Stock (held in my name or my wife's name)
2024-04-30$90.87/sh−3,001$272,701→ 200,912 total

Holdings

Common Stock (ROTH IRA)
114.833
Common Stock - Fam. Partnership (LR Ent.)
28,000
Common Stock - Fam. Partnership (LFLP)
(indirect: GP)
96,000
Common Stock - Family LP (BFLP)
(indirect: GP)
30,000
Option to Purchase Common Stock [2020 Grant]
Exercise: $64.64From: 2021-05-07Exp: 2025-05-06→ Common Stock (5,000 underlying)
5,000
Option to Purchase Common Stock [2021 Grant]
Exercise: $71.64From: 2022-05-06Exp: 2023-05-05→ Common Stock (7,500 underlying)
7,500
Option to Purchase Common Stock [2023 Grant]
Exercise: $55.75From: 2024-05-04Exp: 2028-05-03→ Common Stock (7,500 underlying)
7,500
Option to Purchase Common Stock [2022 Grant]
Exercise: $69.19From: 2023-05-05Exp: 2024-05-04→ Common Stock (7,500 underlying)
7,500

Footnotes (4)

[F1]These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 9, 2019. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
[F2]Transaction totaled on the line below for securities of this title.
[F3]Shares were withheld by the Company to pay the exercise price.
[F4]Total amount for this title following transactions reported on this form.

Documents

1 file